GLP-1 Medication in Houston, Texas: Telehealth Access, Costs, and How to Get Started

GLP-1 medications are now accessible across Houston and throughout Texas through telehealth platforms that connect residents to licensed providers and licensed compounding pharmacies without requiring an in-person visit.

*Compounded semaglutide and tirzepatide are not FDA-approved. This article is for informational purposes only and does not constitute medical advice. Results vary. Consult a licensed healthcare provider before starting any medication.*

---

Houston is the fourth-largest city in the United States, and it has one of the most significant obesity rates of any major American metro. According to data from the Robert Wood Johnson Foundation, Texas consistently ranks among the states with the highest adult obesity prevalence, and within Texas, the Houston metropolitan area reflects those statewide trends.

GLP-1 receptor agonists, which include semaglutide and tirzepatide, represent a genuine clinical advance in managing obesity as a chronic metabolic condition. And for Houston residents, telehealth has transformed what access to these medications looks like in practice. You no longer need a specialist referral, a weeks-long wait, or even a trip to a clinic. A licensed provider can evaluate you, issue a prescription, and have medication shipped to your Houston address, all without an in-person appointment.

---

What GLP-1 Medications Are Available in Houston?

Two GLP-1 medications are widely used for weight management across the Houston area:

Semaglutide is the active pharmaceutical ingredient in Ozempic (FDA-approved for type 2 diabetes) and Wegovy (FDA-approved for chronic weight management in adults). It works by activating GLP-1 receptors in the gut and brain, slowing gastric emptying, reducing appetite, and helping the body recognize satiety sooner. It is administered as a once-weekly subcutaneous injection.

Tirzepatide is a dual GIP/GLP-1 receptor agonist and the active ingredient in Mounjaro (approved for type 2 diabetes) and Zepbound (approved for obesity). By activating two complementary hormonal pathways at once, tirzepatide has produced some of the strongest average weight loss outcomes in the clinical trial record. It is also administered as a weekly injection.

Through telehealth, Houston residents can access compounded versions of both medications. Compounded semaglutide and tirzepatide are prepared by licensed 503A compounding pharmacies and dispensed under direct clinician supervision. These are not FDA-approved finished pharmaceutical products, but they provide a legal, medically supervised path to accessing these active ingredients at significantly lower cost than brand-name alternatives.

---

Do You Need an In-Person Appointment in Texas?

No. Texas law permits telehealth as a valid standard of care. Under the Texas Occupations Code and rules from the Texas Medical Board, licensed physicians can establish a patient-physician relationship and prescribe medication via synchronous audio-visual consultation, provided the evaluation meets applicable clinical standards.

This means your health intake, provider review, and prescription can all happen online, from your home in Houston, Sugar Land, Katy, The Woodlands, or anywhere else in Texas.

For Houston residents, this matters practically. Houston traffic is among the worst in the country. Removing the requirement to travel to a clinic for an evaluation removes one of the most real friction points in starting a weight management program.

---

What Does GLP-1 Medication Cost in Houston?

Cost is the first question most people ask, and the gap between brand-name and compounded options is significant.

Brand-name medications without insurance:

• Ozempic: approximately $900 to $1,100 per month
• Wegovy: approximately $1,300 to $1,500 per month
• Zepbound (tirzepatide): approximately $1,000 to $1,200 per month

Most commercial insurance plans require prior authorization for GLP-1 medications prescribed for weight loss, and approvals are frequently denied or delayed. Texas Medicaid does not broadly cover GLP-1 medications for obesity in adults as of 2026.

Compounded semaglutide and tirzepatide via Prescriva:

• Compounded semaglutide: starting around $199 to $299 per month
• Compounded tirzepatide: starting around $249 to $349 per month

Pricing includes the medication, supplies, and ongoing provider oversight. There are no hidden charges.

Compounded semaglutide and tirzepatide are not the same as brand-name Ozempic, Wegovy, Mounjaro, or Zepbound. They are prepared by licensed 503A pharmacies using the same active pharmaceutical ingredient, but the finished compounded products are not FDA-approved and have not been individually studied in their own clinical trials. For people who cannot access or afford brand-name versions, compounded options provide a medically supervised alternative at a fraction of the cost.

---

What Does the Clinical Evidence Show?

GLP-1 medications have an unusually strong clinical evidence base. Several large randomized controlled trials provide the foundational data.

The STEP 1 trial, published in the *New England Journal of Medicine* in 2021, enrolled 1,961 adults with obesity or overweight plus at least one weight-related condition. Participants receiving semaglutide 2.4 mg weekly lost a mean of 14.9% of body weight over 68 weeks, compared to 2.4% with placebo. [1] This was a landmark result in metabolic medicine.

The SURMOUNT-1 trial, published in the *New England Journal of Medicine* in 2022, examined tirzepatide across three doses in 2,539 adults with obesity. At the 15 mg dose, participants lost a mean of 20.9% of body weight over 72 weeks. Approximately 37% of participants at the highest dose achieved weight loss of 25% or more. [2]

Real-world data supports the trial evidence. A 2026 study published in *Obesity* followed approximately 4,500 patients receiving semaglutide through a telehealth platform. Among the 655 patients with data through week 68, mean body weight reduction was 16.6%, with a safety profile consistent with Phase 3 clinical trial findings. [3]

These figures represent averages across clinical populations. Individual results vary based on starting weight, medication adherence, dose escalation, and lifestyle factors. Your provider can offer a realistic picture of what to expect based on your specific health history.

---

How the Process Works

Getting started takes about 10 to 15 minutes.

Step 1: Complete your health intake online. Answer questions about your medical history, current medications, weight history, and health goals. This intake gives your provider the information they need to evaluate whether treatment is appropriate for you.

Step 2: A licensed provider reviews your intake. A clinician reviews your submission and determines whether a GLP-1 medication fits your clinical profile. If you qualify, they issue a prescription to a licensed 503A compounding pharmacy.

Step 3: Your medication ships to your Houston address. The pharmacy prepares your compounded medication and ships it directly to you, with all necessary supplies included. Most orders arrive within a few business days.

Step 4: Ongoing monitoring and dose adjustments. Prescriva's model includes structured follow-up to track your progress, guide dose titration as your body adjusts, and support you through any questions that come up during treatment.

---

Who Qualifies for GLP-1 Treatment?

Most programs follow clinical criteria aligned with FDA guidance and the evidence base from major trials:

• BMI of 30 or higher (obesity classification), OR
• BMI of 27 or higher with at least one weight-related condition, such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea

Standard exclusions include a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, active pancreatitis, or current pregnancy. Your provider reviews your full history during the evaluation.

You do not need to pre-determine your eligibility. That is the purpose of the clinical evaluation.

---

Why GLP-1 Demand Is High in Houston

Houston's demographic profile is closely tied to the clinical drivers of obesity. Texas as a whole has an adult obesity prevalence of approximately 37%, among the highest nationally. Within Houston, the concentration of the energy industry, healthcare sector, and a large, economically diverse population creates a city where many adults are managing chronic metabolic conditions without adequate access to specialist care.

Endocrinologists in Houston often carry waitlists of several weeks. Primary care providers are managing high patient volumes. GLP-1 medications were historically difficult to access efficiently through in-person systems. Telehealth changes that equation by removing geography and scheduling friction from the access pathway.

There is also a meaningful scientific reason why these medications are gaining traction beyond weight loss interest: obesity is now understood as a chronic hormonal and neurological condition, not a behavioral failure. Research published in *Clinical Science* established that after significant weight loss, the body produces elevated levels of appetite-stimulating hormones and suppresses satiety hormones, creating a persistent biological drive toward weight regain. [4] GLP-1 medications address these hormonal pathways directly, which is why they produce durable results in ways that caloric restriction alone often does not.

---

Frequently Asked Questions

Is compounded semaglutide legal in Texas?

Yes. Compounded semaglutide prepared by a licensed 503A compounding pharmacy and prescribed by a licensed Texas provider is legal. These medications are not FDA-approved finished products. Compounding pharmacies that prepare them operate under state and federal pharmacy law, and each prescription must be issued by a licensed clinician based on individual patient evaluation.

How quickly can I get started in Houston?

Most patients receive a provider decision within 24 to 72 hours of completing their health intake. Once your prescription is issued, medication typically arrives within a few business days. From completing your intake to receiving your first shipment, the process commonly takes five to seven days.

Does Prescriva serve patients across the Houston metro area?

Yes. Prescriva is a telehealth platform licensed to serve patients across Texas. Whether you are in Houston proper, or in surrounding areas like The Woodlands, Sugar Land, Katy, Pearland, or Pasadena, you can use Prescriva's services. Because care is fully online, your location within the metro does not affect access or pricing.

What is the difference between compounded and brand-name GLP-1 medication?

Brand-name medications like Ozempic, Wegovy, Mounjaro, and Zepbound completed the FDA approval process as finished pharmaceutical products and have been evaluated in large-scale clinical trials. Compounded semaglutide and tirzepatide are prepared by licensed 503A pharmacies using the same active pharmaceutical ingredient. The finished compounded products are not FDA-approved and have not been individually studied in their own trials. Both require a valid prescription from a licensed provider. For a detailed comparison, see [how compounded semaglutide compares to Ozempic](/resources/compounded-semaglutide-vs-ozempic).

Will insurance cover GLP-1 medication in Texas?

Coverage for GLP-1 medications prescribed for weight loss varies significantly by plan. Texas has historically had limited Medicaid coverage for obesity medications. Many commercial plans require prior authorization, and approvals can be inconsistent. If your insurance does not cover these medications or your claim is denied, compounded options offer a substantially lower out-of-pocket alternative without requiring insurance approval.

---

Learn More

• [How to get a GLP-1 prescription online](/resources/how-to-get-glp1-prescription-online)
• [Who qualifies for GLP-1 medications](/resources/who-qualifies-for-glp1-medications)
• [Compounded semaglutide costs in 2026](/resources/compounded-semaglutide-cost-2026)
• [Compounded tirzepatide costs in 2026](/resources/compounded-tirzepatide-cost-2026)
• [Compounded semaglutide vs Ozempic](/resources/compounded-semaglutide-vs-ozempic)

---

Sources

1. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. *N Engl J Med.* 2021;384(11):989-1002. [PMID 33567185](https://pubmed.ncbi.nlm.nih.gov/33567185/)
2. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity. *N Engl J Med.* 2022;387(3):205-216. [PMID 35658024](https://pubmed.ncbi.nlm.nih.gov/35658024/)
3. Tchang B et al. Real-world outcomes with telehealth-delivered semaglutide for weight management. *Obesity.* 2026. [PMID 41367196](https://pubmed.ncbi.nlm.nih.gov/41367196/)
4. Sumithran P, Proietto J. The defence of body weight: a physiological basis for weight regain after weight loss. *Clin Sci.* 2013;124(4):231-241. [PMID 23126426](https://pubmed.ncbi.nlm.nih.gov/23126426/)

---

*Compounded semaglutide and tirzepatide are not FDA-approved. This content is for informational purposes only and does not constitute medical advice. Individual results vary. Consult a licensed healthcare provider before starting any medication or treatment program. Care at Prescriva is delivered by independently licensed providers, not by Prescriva LLC, doing business as Prescriva, which is a management services organization.*